ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ)
$3.08 -0.03 (-0.9646%)
Analysed ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) News Sources
Constellation Software Inc., Topicus.com Inc. and Lumine Group Inc. Announce Annual Meetings
10-04-2026
yahoo.com
The Oncology Institute to Participate in the 25th Annual Needham Healthcare Conference
09-04-2026
yahoo.com
The Oncology Institute Names Minh Merchant Chief Legal Officer
06-04-2026
yahoo.com
TSX Stocks Including Montage Gold That May Be Trading Below Intrinsic Value Estimates
03-04-2026
yahoo.com
One Oncology Institute Insider Raised Their Stake In The Previous Year
31-03-2026
yahoo.com
Oncology Institute (TOI) Earnings Transcript
17-03-2026
fool.com
The Oncology Institute, Inc. Q4 2025 Earnings Call Summary
13-03-2026
moby.co
The Oncology Institute Inc (TOI) Q4 2025 Earnings Call Highlights: Record Revenue and First ...
13-03-2026
yahoo.com
Oncology Institute Q4 Earnings Call Highlights
13-03-2026
marketbeat.com
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026
12-03-2026
yahoo.com
What is the current price of ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ)?
The current price of ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) is $3.08.
ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) absolute price change since previous trading day?
The absolute price change of ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) since the previous trading day is $-0.03.
ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) percentage price change since previous trading day?
The percentage price change of ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) since the previous trading day is -0.9646%.
What is the most recent average sentiment score for ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ)?
The most recent average sentiment score for ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ)?
The most recent sentiment for ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ) is .
SEC-8K** Filing Available For ONCOLOGY INSTITUTE INC/THE (TOI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.